Skip to main content
BrainCited

Ginkgo biloba for Age-Related Cognitive Decline

C

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

Key Study Findings

Review
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?
Dose: None vs: placebo Outcome: cognitive assessment scores (MMSE, SKT, NPI) Effect: None None

Population: patients with mild-to-moderate Alzheimer disease or vascular dementia

Review
Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.
Dose: None vs: None Outcome: None Effect: None None

Population: patients with vascular cognitive impairment and dementia

Review
The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.
Dose: None vs: None Outcome: None Effect: None None

Population: Review of natural products for neuroprotection

Review
Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review.
Dose: None vs: None Outcome: Cognitive function in multiple sclerosis Effect: None None

Population: Multiple sclerosis patients (review)

Review
Nutritional strategies against dementia in rural populations.
Dose: None vs: None Outcome: None Effect: None None

Population: Rural populations with dementia risk

Cohort Study n=64 52 weeks Open-label
Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment.
Dose: 240 mg/day vs: Standard cognitive enhancers Outcome: Cognitive responder rate and AD conversion Effect: 100% vs 59.1% responders; 0% vs 13.6% AD conversio <0.001 (responders); 0.037 (AD

Population: Amyloid PET-positive MCI patients

Key Statistics

40

Studies

8000

Participants

Mixed

C

Grade

Referenced Papers

Pharmaceuticals (Basel, Switzerland) 2021 33 citations
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 4 citations
Acta bio-medica : … 2018 103 citations
Journal of Alzheimer's … 2017 17 citations
Age (Dordrecht, Netherlands) 2014
American family physician 2011
JAMA 2010 3 citations
The Practitioner 2010
The Cochrane database … 2009 299 citations
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 citations
The Proceedings of … 2002 191 citations
The Cochrane database … 2002
Current opinion in … 1998 30 citations
British journal of … 1993 8 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

Upper limit: 600 mg/day (doses above show no additional benefit)

Dosages Studied in Research

Dosage Duration Effect N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
240 mg/day 52 weeks Positive 64
None -- Positive --
None -- Neutral --

Best taken: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

Reported Side Effects

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

Known Interactions

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

Tolerable upper intake: 600 mg/day (doses above show no additional benefit)

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Ginkgo biloba help with Age-Related Cognitive Decline?
Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Ginkgo biloba should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.